Search trials for
Showing NN of NN trials
Enrolling

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants...

This study [contRAst 1 (201790: NCT03980483)] is a phase 3, randomized, multicenter, double blind study to assess the safety and...

Enrolling

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arth...

The purpose of this study is to examine the long-term safety of Abatacept for the treatment of juvenile idiopathic arthritis...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthr...

Evaluate long-term safety and tolerability of tofacitinib in patients with JIA, who have previously participated in tofacitinib JIA studies.

Enrolling

A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) as Monoth...

This open-label, single arm study will evaluate the efficacy and safety of subcutaneously administered RoActemra/Actemra (tocilizumab), in monotherapy or in...

Enrolling

Comparative Pharmacokinetic, Pharmacodynamic, Safety and Efficacy Study of Three...

This study will compare the plasma pharmacokinetic profile and the change in disease activity score in patients with active rheumatoid...

Enrolling

Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active...

This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in...

Enrolling

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subje...

This is a randomized, double-blinded, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of tildrakizumab compared to placebo...

Enrolling

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants...

This study [contRAst 2 (201791: NCT03970837)] is a phase 3, randomized, multicenter, double blind study to assess the safety and...

Enrolling

Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT...

This research will help doctors interested in the usefulness of a new test to discover hidden tuberculosis infections in patients...

Enrolling

Evaluation of the Long Term Safety, Tolerability and Efficacy of Two Dosing Regi...

The purpose of the study is to evaluate how safe, how effective and how well tolerated, the study drug Olokizumab...

Enrolling

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participa...

Study to evaluate the safety and effectiveness of treatment with branebrutinib treatment in participants with active systemic Lupus Erythematosus (SLE)...

Enrolling

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients W...

An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of RemsimaTM in Patients with Rheumatoid Arthritis.

Enrolling

OTIS Autoimmune Diseases in Pregnancy Project

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain...

Enrolling

Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthrit...

The multicenter, randomized controlled trial is to investigate and evaluate the effect of NSAIDs therapy on recurrence in patients with...

Enrolling

Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 In...

The purpose of this two-part study is to assess the efficacy, safety and tolerability of multiple intra-articular (i.a.) injections of...

Enrolling

A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study o...

This study is the first administration of GSK3858279 in humans and will be conducted in two parts: Part A will...

Not Yet Enrolling

CTHRC1 Abiomarker in Rheumatoid Arthritis Diagnosis

The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein...

Not Yet Enrolling

Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single D...

This is a Phase 1, open-label, 3-period, single-sequence, crossover study to evaluate potential effects of olokizumab on pharmacokinetics (PK) of...

Not Yet Enrolling

A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Oste...

This is a Phase 3, Multicenter, 22-Week, double-blind and 30-Week open label Study to Evaluate the Efficacy and Safety of...

Not Yet Enrolling

A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Oste...

This is a Phase 3, Multicenter, Randomized, 22 Week, Double-Blind, Placebo Controlled and 3-Week, Open-Label Study to Evaluate the Efficacy...